Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8607178
[patent_doc_number] => 20130012491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'PYRIMIDINE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/635499
[patent_app_country] => US
[patent_app_date] => 2011-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26471
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635499
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/635499 | PYRIMIDINE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS | Mar 15, 2011 | Abandoned |
Array
(
[id] => 6102627
[patent_doc_number] => 20110166120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH'
[patent_app_type] => utility
[patent_app_number] => 13/045923
[patent_app_country] => US
[patent_app_date] => 2011-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61499
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166120.pdf
[firstpage_image] =>[orig_patent_app_number] => 13045923
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/045923 | Sulfonyl amide derivatives for the treatment of abnormal cell growth | Mar 10, 2011 | Issued |
Array
(
[id] => 9227554
[patent_doc_number] => 08633222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Arylvinylazacycloalkane compounds and methods of preparation and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/033719
[patent_app_country] => US
[patent_app_date] => 2011-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13821
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13033719
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/033719 | Arylvinylazacycloalkane compounds and methods of preparation and use thereof | Feb 23, 2011 | Issued |
Array
(
[id] => 9009429
[patent_doc_number] => 08524728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase'
[patent_app_type] => utility
[patent_app_number] => 13/027793
[patent_app_country] => US
[patent_app_date] => 2011-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25785
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13027793
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/027793 | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase | Feb 14, 2011 | Issued |
Array
(
[id] => 10831599
[patent_doc_number] => 08859769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine'
[patent_app_type] => utility
[patent_app_number] => 13/521780
[patent_app_country] => US
[patent_app_date] => 2011-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7923
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521780
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/521780 | Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine | Feb 14, 2011 | Issued |
Array
(
[id] => 8510359
[patent_doc_number] => 20120309767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'PROCESS FOR THE PREPARATION OF ALPHA FORM OF IMATINIB MESYLATE'
[patent_app_type] => utility
[patent_app_number] => 13/578918
[patent_app_country] => US
[patent_app_date] => 2011-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7372
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578918
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/578918 | PROCESS FOR THE PREPARATION OF ALPHA FORM OF IMATINIB MESYLATE | Feb 14, 2011 | Abandoned |
Array
(
[id] => 6186553
[patent_doc_number] => 20110124646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'Novel cyclic compound having pyrimidinylalkylthio group'
[patent_app_type] => utility
[patent_app_number] => 12/931072
[patent_app_country] => US
[patent_app_date] => 2011-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20499
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124646.pdf
[firstpage_image] =>[orig_patent_app_number] => 12931072
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/931072 | Cyclic compound having pyrimidinylalkylthio group | Jan 23, 2011 | Issued |
Array
(
[id] => 9227515
[patent_doc_number] => 08633183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => '5-alkynyl-pyrimidines'
[patent_app_type] => utility
[patent_app_number] => 13/012082
[patent_app_country] => US
[patent_app_date] => 2011-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32877
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13012082
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/012082 | 5-alkynyl-pyrimidines | Jan 23, 2011 | Issued |
Array
(
[id] => 8772463
[patent_doc_number] => 08426419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-23
[patent_title] => 'Tyrosine kinase inhibitors containing a zinc binding moiety'
[patent_app_type] => utility
[patent_app_number] => 13/010542
[patent_app_country] => US
[patent_app_date] => 2011-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21675
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13010542
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/010542 | Tyrosine kinase inhibitors containing a zinc binding moiety | Jan 19, 2011 | Issued |
Array
(
[id] => 10857586
[patent_doc_number] => 08883785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/575019
[patent_app_country] => US
[patent_app_date] => 2011-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23906
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575019
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575019 | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | Jan 19, 2011 | Issued |
Array
(
[id] => 5944915
[patent_doc_number] => 20110105535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE'
[patent_app_type] => utility
[patent_app_number] => 13/005132
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26005
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105535.pdf
[firstpage_image] =>[orig_patent_app_number] => 13005132
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/005132 | Inhibitors of phosphatidylinositol 3-kinase | Jan 11, 2011 | Issued |
Array
(
[id] => 5986947
[patent_doc_number] => 20110098280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => '2,4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/984519
[patent_app_country] => US
[patent_app_date] => 2011-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72538
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098280.pdf
[firstpage_image] =>[orig_patent_app_number] => 12984519
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/984519 | 2,4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS | Jan 3, 2011 | Abandoned |
Array
(
[id] => 6055934
[patent_doc_number] => 20110112294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => '1-[2\', 3\' -DIDEOXY-3\' C- (HYDROXYMETHYL) - BETA-D-ERYTHRO-PENTOFURANOSYL] CYTOSINE DERIVATIVES AS HIV INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/982667
[patent_app_country] => US
[patent_app_date] => 2010-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18762
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112294.pdf
[firstpage_image] =>[orig_patent_app_number] => 12982667
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/982667 | 1-[2′, 3′ -dideoxy-3′ C- (hydroxymethyl)—beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors | Dec 29, 2010 | Issued |
Array
(
[id] => 9648661
[patent_doc_number] => 08802672
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Pyrimidinyl-piperazines useful as D3/D2 receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 12/979439
[patent_app_country] => US
[patent_app_date] => 2010-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9938
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12979439
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/979439 | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands | Dec 27, 2010 | Issued |
Array
(
[id] => 10057200
[patent_doc_number] => 09096544
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Therapeutic compounds'
[patent_app_type] => utility
[patent_app_number] => 13/519098
[patent_app_country] => US
[patent_app_date] => 2010-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27435
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519098
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/519098 | Therapeutic compounds | Dec 22, 2010 | Issued |
Array
(
[id] => 8177282
[patent_doc_number] => 08178530
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 12/970632
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 54686
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12970632
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/970632 | Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases | Dec 15, 2010 | Issued |
Array
(
[id] => 6090505
[patent_doc_number] => 20110218178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/970659
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 54679
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218178.pdf
[firstpage_image] =>[orig_patent_app_number] => 12970659
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/970659 | Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases | Dec 15, 2010 | Issued |
Array
(
[id] => 8063727
[patent_doc_number] => 20110245205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'AMINOPYRIMIDINES AS SYK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/968608
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 191455
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245205.pdf
[firstpage_image] =>[orig_patent_app_number] => 12968608
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/968608 | Aminopyrimidines as SYK inhibitors | Dec 14, 2010 | Issued |
Array
(
[id] => 8477794
[patent_doc_number] => 20120277192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'AMINOPYRIMIDINES AS SYK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/516455
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 191515
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516455
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/516455 | Aminopyrimidines as SYK inhibitors | Dec 14, 2010 | Issued |
Array
(
[id] => 6183633
[patent_doc_number] => 20110123490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'HETEROCYCLIC ANTIVIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/967657
[patent_app_country] => US
[patent_app_date] => 2010-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15112
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20110123490.pdf
[firstpage_image] =>[orig_patent_app_number] => 12967657
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/967657 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | Dec 13, 2010 | Abandoned |